The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the ...

Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

The Federal Trade Commission (FTC) has sued the top three ... system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin ... the Federal Trade Commission alleged in ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

Citation: New type of insulin that switches on and off could help diabetics avoid sudden drops in blood sugar levels (2024, October 16) retrieved 11 November 2024 from https://medicalxpress.com ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

CVS (CVS) and UnitedHealth Group (UNH) on Tuesday demanded that Federal Trade Commission (FTC ... of artificially inflating the list prices of insulin drugs and shifted that cost to vulnerable ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

In September, the Federal Trade Commission announced a lawsuit against the nation’s three biggest PBMs, alleging they created a system that inflated insulin prices. The companies denied the claims.